Bafna Pharmaceuticals’ unit gets renewal approval from MHRA

28 May 2018 Evaluate

Bafna Pharmaceuticals’ facility has received renewal approval as per the Guidelines of European Good Manufacturing Practices (EUGMP) from Medicines and Healthcare products Regulatory Agency (MHRA).

Bafna Pharmaceuticals is engaged in the production of tablets, capsule and oral syrup.

Bafna Pharma Share Price

121.90 5.45 (4.68%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×